PIERUZZI FEDERICO UMBERTO EMILIO GUGLIE

Mignani, R., & Pieruzzi, F. (2022). Safety of a protocol for reduction of agalsidase beta infusion time in Fabry disease: An Italian multi-centre study. MOLECULAR GENETICS AND METABOLISM REPORTS, 30(March 2022) [10.1016/j.ymgmr.2021.100838]. Dettaglio

Jayne, D., Merkel, P., Schall, T., Bekker, P., & Pieruzzi, F. (2021). Avacopan for the treatment of ANCA-associated vasculitis. NEW ENGLAND JOURNAL OF MEDICINE, 384(7), 599-609 [10.1056/NEJMoa2023386]. Dettaglio

Postorino, M., Lizio, D., De Mauri, A., Marino, C., Tripepi, G., Zoccali, C., et al. (2021). Radiation dose from medical imaging in end stage renal disease patients: a Nationwide Italian Survey. JN. JOURNAL OF NEPHROLOGY. Dettaglio

Fogazzi, G., Garigali, G., Pieruzzi, F., Corbelli, A., Fiordaliso, F., Consonni, D., et al. (2021). A morphological classification of the fat particles found in the urinary sediment of patients with Fabry disease. CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 59(11), 1832-1843 [10.1515/cclm-2021-0079]. Dettaglio

Pieroni, M., Pieruzzi, F., Mignani, R., Graziani, F., Olivotto, I., Riccio, E., et al. (2021). Potential resistance to SARS-CoV-2 infection in lysosomal storage disorders. CLINICAL KIDNEY JOURNAL, 14(5), 1488-1490 [10.1093/ckj/sfab045]. Dettaglio